Prediction-Oriented Marker Selection (PROMISE): With Application to High-Dimensional Regression

Soyeon Kim (), Veerabhadran Baladandayuthapani () and J. Jack Lee ()
Additional contact information
Soyeon Kim: Rice University
Veerabhadran Baladandayuthapani: The University of Texas MD Anderson Cancer Center
J. Jack Lee: The University of Texas MD Anderson Cancer Center

Statistics in Biosciences, 2017, vol. 9, issue 1, No 12, 217-245

Abstract: Abstract In personalized medicine, biomarkers are used to select therapies with the highest likelihood of success based on an individual patient’s biomarker/genomic profile. Two goals are to choose important biomarkers that accurately predict treatment outcomes and to cull unimportant biomarkers to reduce the cost of biological and clinical verifications. These goals are challenging due to the high dimensionality of genomic data. Variable selection methods based on penalized regression (e.g., the lasso and elastic net) have yielded promising results. However, selecting the right amount of penalization is critical to simultaneously achieving these two goals. Standard approaches based on cross-validation (CV) typically provide high prediction accuracy with high true positive rates (TPRs) but at the cost of too many false positives. Alternatively, stability selection (SS) controls the number of false positives, but at the cost of yielding too few true positives. To circumvent these issues, we propose prediction-oriented marker selection (PROMISE), which combines SS with CV to conflate the advantages of both methods. Our application of PROMISE with the lasso and elastic net in data analysis shows that, compared to CV, PROMISE produces sparse solutions, few false positives, and small type I + type II error, and maintains good prediction accuracy, with a marginal decrease in the TPRs. Compared to SS, PROMISE offers better prediction accuracy and TPRs. In summary, PROMISE can be applied in many fields to select regularization parameters when the goals are to minimize false positives and maximize prediction accuracy.

Keywords: Predictive marker; Personalized medicine; Cross-validation; Stability selection; Variable selection; Lasso (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s12561-016-9169-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:stabio:v:9:y:2017:i:1:d:10.1007_s12561-016-9169-5

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/12561

DOI: 10.1007/s12561-016-9169-5

Access Statistics for this article

Statistics in Biosciences is currently edited by Hongyu Zhao and Xihong Lin

More articles in Statistics in Biosciences from Springer, International Chinese Statistical Association
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().